Page 299 - HIVMED_v21_i1.indb

Page 9 of 10 Original Research

References 24. Akullian AN, Mukose A, Levine GA, Babigumira JB. People living with HIV travel
farther to access healthcare: A population-based geographic analysis from
rural Uganda. J Int AIDS Soc. 2016;19(1):20171. https://doi.org/10.7448/
IAS.19.1.20171
1. World Health Organization. Consolidated guidelines on the use of antiretroviral
drugs for treating and preventing HIV infection: Recommendations for a 25. Buor D. Analysing the primacy of distance in the utilization of health services
public health approach [homepage on the Internet]. WHO Guidelines. 2013 in the Ahafo-Ano South district, Ghana. Int J Health Plann Manage.
[cited 2019 Aug 14]. Available from: https://apps.who.int/iris/bitstream/ 2003;18(4):293–311. https://doi.org/10.1002/hpm.729
handle/10665/85321/9789241505727_eng.pdf?sequence=1 26. Schoeps A, Gabrysch S, Niamba L, Sié A, Becher H. The effect of distance to health-
2. Fox MP, Berhanu R, Steegen K, et al. Intensive adherence counselling for HIV- care facilities on childhood mortality in rural Burkina Faso. Am J Epidemiol.
infected individuals failing second-line antiretroviral therapy in Johannesburg, 2011;173(5):492–498. https://doi.org/10.1093/aje/kwq386
South Africa. Trop Med Int Heal. 2016;21(9):1131–1137. https://doi.org/10.1111/
tmi.12741 27. Cluver LD, Hodes RJ, Toska E, et al. ‘HIV is like a tsotsi. ARVs are your guns’:
Associations between HIV-disclosure and adherence to antiretroviral treatment
3. Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing among adolescents in South Africa. AIDS. 2015;29 Suppl 1:S57–65. https://doi.
medication adherence. Cochrane Database Syst Rev. 2014;11:1–538. https://doi. org/10.1097/QAD.0000000000000695
org/10.1002/14651858.CD000011.pub4
28. Rochat TJ, Mkwanazi N, Bland R. Maternal HIV disclosure to HIV-uninfected
4. World Health Organization. Guideline on when to start antiretroviral therapy and children in rural South Africa: A pilot study of a family-based intervention. BMC
on pre-exposure prophylaxis for HIV [homepage on the Internet]. World Health
Organization; 2015 [cited 2019 Aug 14]. Available from: https://apps.who.int/iris/ Public Health. 2015;29 Suppl 1:S57–65. https://doi.org/10.1186/1471-2458-
bitstream/handle/ 10665/186275/9789241509565_eng.pdf?sequence=1 13-147
5. Goudge J, Ngoma B. Exploring antiretroviral treatment adherence in an urban 29. Wouters E, Van Loon F, Van Rensburg D, Meulemans H. Community support and
setting in South Africa. J Public Health Policy. 2011;32:S52–S64. https://doi. disclosure of HIV serostatus to family members by public-sector antiretroviral
org/10.1057/jphp.2011.22 treatment patients in the Free State Province of South Africa. AIDS Patient Care
STDS. 2009;23(5):357–364. https://doi.org/10.1089/apc.2008.0201
6. Elliott JH, Lynen L, Calmy A, et al. Rational use of antiretroviral therapy in low-income
and middle-income countries: Optimizing regimen sequencing and switching. AIDS. 30. Kunutsor S, Walley J, Katabira E, et al. Improving clinic attendance and adherence
2008;22(16):2053–2067. https://doi.org/10.1097/QAD.0b013e328309520d to antiretroviral therapy through a treatment supporter intervention in Uganda: A
randomized controlled trial. AIDS Behav. 2011;15(8):1795–1802. https://doi.
7. Gross R, Zheng L, Rosa A La, et al. Partner-based adherence intervention for
second-line antiretroviral therapy (ACTG A5234): A multinational randomised org/10.1007/s10461-011-9927-9
trial. Lancet HIV. 2(1):e12–19. https://doi.org/10.1016/S2352-3018(14)00007-1 31. Nachega JB, Chaisson RE, Goliath R, et al. Randomized controlled trial of
8. Onoya D, Nattey C, Budgell E, et al. Predicting the need for third-line antiretroviral trained patient-nominated treatment supporters providing partial directly
therapy by identifying patients at high risk for failing second-line antiretroviral observed antiretroviral therapy. AIDS. 24(9):1273–1280. https://doi.org/10.1097/
therapy in South Africa. AIDS Patient Care STDS. 31(5):205–212. https://doi. QAD.0b013e328339e20e
org/10.1089/apc.2016.0291 32. Duwell MM, Knowlton AR, Nachega JB, et al. Patient-nominated, community-
9. Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL. No room for complacency based HIV treatment supporters: Patient perspectives, feasibility, challenges, and
about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS. factors for success in HIV-infected South African adults. AIDS Patient Care STDS.
2005;19(12):1243–1249. https://doi.org/10.1097/01.aids.0000180094.04652.3b 2013;27(2):96–102. https://doi.org/10.1089/apc.2012.0348
10. South African National Department of Health. National consolidated guidelines 33. Kanters S, Park JJH, Chan K, et al. Interventions to improve adherence to
for the prevention of mother-to-child transmission of HIV (PMTCT) and the antiretroviral therapy: A systematic review and network meta-analysis. Lancet
management of HIV in children, adolescents and adults [homepage on the Internet]. HIV. 2017; 4(1):e31–e40. https://doi.org/10.1016/S2352-3018(16)30206-5
Health Policy. 2015 [cited 2019 Aug 20]. Available from: https://sahivsoc.org/Files/
ARTGuidelines15052015.pdf 34. Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: A systematic
review of developed and developing nation patient-reported barriers
11. Nnambalirwa M, Govathson C, Evans D, McNamara L, Maskew M, Nyasulu P. and facilitators. PLoS Med. 2006;3(11):e438. https://doi.org/10.1371/journal.
Markers of poor adherence among adults with HIV attending Themba Lethu HIV pmed.0030438
Clinic, Helen Joseph Hospital, Johannesburg, South Africa. Trans R Soc Trop Med
Hyg. 2016;110(12):696–704. https://doi.org/10.1093/trstmh/trx003 35. Ajose O, Mookerjee S, Mills EJ, Boulle A, Ford N. Treatment outcomes of patients on
12. World Health Organization. HIV drug resistance report 2017 [homepage on the second-line antiretroviral therapy in resource-limited settings: A systematic review
and meta-analysis. AIDS. 2012. https://doi.org/10.1097/QAD.0b013e328351f5b2
Internet]. World Health Organization; 2017 [cited 2019 Aug 20]. Available from:
https://apps.who.int/iris/bitstream/handle/10665/255896/9789241512831-eng. 36. Cheng Y, Nickman NA, Jamjian C, et al. Predicting poor adherence to
pdf?sequence=1 antiretroviral therapy among treatment-naïve veterans infected with human
13. Hertogs K, Bloor S, De Vroey V, et al. A novel human immunodeficiency virus type immunodeficiency virus. Medicine. 2018;97(2):e9495. https://doi.org/10.1097/
1 reverse transcriptase mutational pattern confers phenotypic lamivudine MD.0000000000009495
resistance in the absence of mutation 184V. Antimicrob Agents Chemother. 2000; 37. Petersen ML, Wang Y, Van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Pillbox
44(3):568–573. https://doi.org/10.1128/AAC.44.3.568-573.2000 organizers are associated with improved adherence to HIV antiretroviral therapy
14. Achappa B, Madi D, Bhaskaran U, Ramapuram JT, Rao S, Mahalingam S. Adherence and viral suppression: A marginal structural model analysis. Clin Infect Dis.
to antiretroviral therapy among people living with HIV. N Am J Med Sci. 2007;45(7):908–915. https://doi.org/10.1086/521250
2013;5(3):220–223. https://doi.org/10.4103/1947-2714.109196 38. Azia IN, Mukumbang FC, Van Wyk B. Barriers to adherence to antiretroviral
15. Pagès-Puigdemont N, Mangues MA, Masip M, et al. Patients’ perspective of treatment in a regional hospital in Vredenburg, Western Cape, South Africa. South
medication adherence in chronic conditions: A qualitative study. Adv Ther. 2016; Afr J HIV Med. 2016;17(1):476. https://doi.org/10.4102/sajhivmed.v17i1.476
33:1740–1754. https://doi.org/10.1007/s12325-016-0394-6 39. Nozaki I, Dube C, Kakimoto K, Yamada N, Simpungwe JB. Social factors affecting
16. Laba TL, Lehnbom E, Brien J-A, Jan S. Understanding if, how and why non- ART adherence in rural settings in Zambia. AIDS Care. 2011;23(7):831–838.
adherent decisions are made in an Australian community sample: A key to https://doi.org/10.1080/09540121.2010.542121
sustaining medication adherence in chronic disease? Res Social Adm Pharm.
2015;11(2):154–162. https://doi.org/10.1016/j.sapharm.2014.06.006 40. Nassir Azmach N. Adherence to antiretroviral therapy and associated factors
among adult ARV users in Arba Minch Hospital, Southern Ethiopia. Cent African J
17. Conroy A, Leddy A, Johnson M, Ngubane T, Van Rooyen H, Darbes L. ‘I told her this Public Heal. 2017;3(2):19–26. https://doi.org/10.11648/j.cajph.20170302.12
is your life’: Relationship dynamics, partner support and adherence to
antiretroviral therapy among South African couples. Cult Heal Sex. 41. Stawarz K, Rodríguez MD, Cox AL, Blandford A. Understanding the use of
2017;19(11):1239–1253. https://doi.org/10.1080/13691058.2017.1309460 contextual cues: Design implications for medication adherence technologies
that support remembering. Digit Heal. 2016; 1;2:2055207616678707. https://
18. Johnson MO, Dilworth SE, Taylor JM, Darbes LA, Comfort ML, Neilands TB. Primary doi.org/10.1177/ 2055207616678707
relationships, HIV treatment adherence, and virologic control. AIDS Behav.
2012;16:1511–1521. https://doi.org/10.1007/s10461-011-0021-0 42. Nkomo G, Mosalo A, Thupayagale-Tshweneagae GB. Adherence to treatment and
retention to care of adult patients on antiretroviral therapy. Afr J Nurs Midwifery.
19. Robards J, Evandrou M, Falkingham J, Vlachantoni A. Marital status, health and 2018;20(1):1–13. https://doi.org/10.25159/2520-5293/1590
mortality. Maturitas. 2012. https://doi.org/10.1016/j.maturitas.2012.08.007
20. Shisana O. South African national HIV prevalence, incidence and behaviour 43. Wasti SP, Simkhada P, Randall J, Freeman JV, Van Teijlingen E. Factors influencing
adherence to antiretroviral treatment in Nepal: A mixed-methods study. PLoS
survey, 2012 [homepage on the Internet]. HSRC Press; 2014 [cited 2019 Aug 21]. One. 2012;7(5):e35547. https://doi.org/10.1371/journal.pone.0035547
Available from: http://repository.hsrc.ac.za/bitstream/handle/20.500.11910/
2490/8162.pdf?sequence=1&isAllowed=y 44. Fonsah JY, Njamnshi AK, Kouanfack C, et al. Adherence to antiretroviral therapy
21. Hadland SE, Milloy M-J, Kerr T, et al. Young age predicts poor antiretroviral (ART) in Yaoundé-Cameroon: Association with opportunistic infections,
adherence and viral load suppression among injection drug users. AIDS Patient depression, ART regimen and side effects. PLoS One. 2017;12(1):e0170893.
Care STDS. 2012;26(5):274–280. https://doi.org/10.1089/apc.2011.0196 https://doi.org/10.1371/journal.pone.0170893
22. Bulage L, Ssewanyana I, Nankabirwa V, et al. Factors associated with virological non- 45. Johnson MO, Dilworth SE, Taylor JM, Neilands TB. Improving coping skills for self-
suppression among HIV-positive patients on antiretroviral therapy in Uganda, August management of treatment side effects can reduce antiretroviral medication
2014-July 2015. BMC Infect Dis. 2017;17(1):326. https://doi.org/10.1186/s12879- nonadherence among people living with HIV. Ann Behav Med. 2011;41(1):83–91.
017-2428-3 https://doi.org/10.1007/s12160-010-9230-4
23. Mujugira A, Celum C, Tappero JW, Ronald A, Mugo N, Baeten JM. Younger age 46. Moyo F, Chasela C, Brennan AT, et al. Treatment outcomes of HIV-positive patients
predicts failure to achieve viral suppression and virologic rebound among HIV-1- on first-line antiretroviral therapy in private versus public HIV clinics in
infected persons in serodiscordant partnerships. AIDS Res Hum Retroviruses. Johannesburg, South Africa. Clin Epidemiol. 2016;8:37–47. https://doi.
2016; 32(2):148–154. https://doi.org/10.1089/aid.2015.0296 org/10.2147/CLEP.S93014
http://www.sajhivmed.org.za 291 Open Access